Joshua Bomsztyk

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Venues

British journal of haematology

Blood

Expert review of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua Bomsztyk, Sriram Ravichandran, Hannah V Giles, Nicola Wright, Oscar Berlanga, Jahanzaib Khwaja, Shameem Mahmood, Brendan Wisniowski, Oliver Cohen, Darren Foard, Janet Gilbertson, Muhammad Umaid Rauf, Neasa Starr, Ana Martinez-Naharro, Lucia Venneri, Carol Whelan, Marianna Fontana, Philip N Hawkins, Julian D Gillmore, Helen Lachmann, Stephen Harding, Guy Pratt, Ashutosh D Wechalekar
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis. Blood 143 (13) (2024)
Jahanzaib Khwaja, Joshua Bomsztyk, Maria Atta, Ceri A Bygrave, Adam Forbes, Senthil Durairaj, Savio Fernandes, James Taylor, Pamela Paterson, Gillian Brearton, Charles Crawley, Oonagh Sheehy, Rachel Brown, Richard Soutar, Mamta Garg, Andrzej Rydzewski, Krzysztof Jamroziak, Shameem Mahmood, Ashutosh D Wechalekar
Real-world efficacy of single-agent belantamab mafodotin in relapsed systemic AL amyloidosis. British journal of haematology (2024)
Jahanzaib Khwaja, Joshua Bomsztyk, Maria Atta, Ceri A Bygrave, Adam Forbes, Senthil Durairaj, Savio Fernandes, James Taylor, Pamela Paterson, Gillian Brearton, Charles Crawley, Oonagh Sheehy, Rachel Brown, Richard Soutar, Mamta Garg, Andrzej Rydzewski, Krzysztof Jamroziak, Shameem Mahmood, Ashutosh D Wechalekar
Real-world efficacy of single-agent belantamab mafodotin in relapsed systemic AL amyloidosis. British journal of haematology 204 (5) (2024)
Joshua Bomsztyk, Sriram Ravichandran, Hannah Victoria Giles, Nicola Jane Wright, Oscar Berlanga, Jahanzaib Khwaja, Shameem Mahmood, Brendan Wisniowski, Oliver C Cohen, Darren Foard, Janet Gilbertson, Muhammad Umaid Rauf, Neasa Starr, Ana Martinez-Naharro, Lucia Venneri, Carol Whelan, Marianna Fontana, Philip N Hawkins, Julian D Gillmore, Helen J Lachmann, Stephen Harding, Guy Pratt, Ashutosh D Wechalekar
Complete responses in AL amyloidosis are unequal - the impact of free light chain mass spectrometry in AL amyloidosis. Blood (2024)
Joshua Bomsztyk, Sriram Ravichandran, Hannah Victoria Giles, Nicola Jane Wright, Oscar Berlanga, Jahanzaib Khwaja, Shameem Mahmood, Brendan Wisniowski, Oliver C Cohen, Darren Foard, Janet Gilbertson, Muhammad Umaid Rauf, Neasa Starr, Ana Martinez-Naharro, Lucia Venneri, Carol Whelan, Marianna Fontana, Philip N Hawkins, Julian D Gillmore, Helen J Lachmann, Stephen Harding, Guy Pratt, Ashutosh D Wechalekar
Complete responses in AL amyloidosis are unequal - the impact of free light chain mass spectrometry in AL amyloidosis. Blood (2024)
Joshua Bomsztyk, Sriram Ravichandran, Jahanzaib Khwaja, Oliver Cohen, Muhammad U Rauf, Darren Foard, Ana Martinez-Naharro, Lucia Venneri, Carol Whelan, Marianna Fontana, Philip N Hawkins, Julian Gillmore, Helen Lachmann, Shameem Mahmood, Ashutosh D Wechalekar
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regime. British journal of haematology (2024)
Joshua Bomsztyk, Sriram Ravichandran, Jahanzaib Khwaja, Oliver Cohen, Muhammad U Rauf, Darren Foard, Ana Martinez-Naharro, Lucia Venneri, Carol Whelan, Marianna Fontana, Philip N Hawkins, Julian Gillmore, Helen Lachmann, Shameem Mahmood, Ashutosh D Wechalekar
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regime. British journal of haematology 205 (1) (2024)
Joshua Bomsztyk, Sriram Ravichandran, Jahanzaib Khwaja, Oliver Cohen, Muhammad U Rauf, Darren Foard, Ana Martinez-Naharro, Lucia Venneri, Carol Whelan, Marianna Fontana, Philip N Hawkins, Julian Gillmore, Helen Lachmann, Shameem Mahmood, Ashutosh D Wechalekar
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regime. British journal of haematology 205 (1) (2024)
Joshua Bomsztyk, Jahanzaib Khwaja, Ashutosh D Wechalekar
Recent guidelines for high-dose chemotherapy and autologous stem cell transplant for systemic AL amyloidosis: a practitioner's perspective. Expert review of hematology 15 (9) (2022)

Joshua Bomsztyk.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joshua Bomsztyk